On the other hand, a study by Ding et al. [58] reported a significant association between children’s ADHD symptoms’ response to a methylphenidate treatment (MPH) with low DNA methylation of DAT1. The gene discussed is SLC6A3; the disease is attention deficit-hyperactivity disorder.